Skip to main content
Microbiology Resource Announcements logoLink to Microbiology Resource Announcements
. 2021 Dec 9;10(49):e00900-21. doi: 10.1128/MRA.00900-21

Near-Complete Genome Sequencing of Influenza C Virus in the Philippines between 2014 and 2019

Daisetsu Fujita a, Clyde Dapat a,✉, Emmanuel Kagning Tsinda a, Mayuko Saito a, Michiko Okamoto a, Mariko Saito-Obata a, Beatriz P Quiambao b, Socorro P Lupisan b, Hitoshi Oshitani a
Editor: Simon Rouxc
PMCID: PMC8656392  PMID: 34881984

ABSTRACT

We report 19 nearly complete genome sequences of influenza C virus isolated from clinical samples recovered from children in the Philippines between 2014 and 2019.

ANNOUNCEMENT

Influenza C virus (ICV), a member of the Orthomyxoviridae family, consists of an antisense single-stranded RNA genome in seven segments: polymerase basic 2 (PB2), polymerase basic 1 (PB1), polymerase 3 (P3), hemagglutinin-esterase (HE), nucleoprotein (NP), matrix (M), and nonstructural (NS). HE protein determines the antigenic properties of ICV, and currently, there are six different lineages (1). ICV mainly causes mild upper respiratory tract illnesses in children. However, sometimes it also causes lower respiratory tract illnesses, such as bronchitis, bronchiolitis, and pneumonia (2–5). ICV has been recognized as a common respiratory pathogen in humans (6–10). In our previous study, we analyzed ICV strains isolated between 2009 and 2013 in the Philippines. We determined the complete sequences of coding regions (CDS) of the HE, M, and NS gene segments and partial sequences of the four internal gene segments; we observed that the composition of the internal genes of the Philippines strains differed from that of Japanese strains (11). In this study, we aimed to determine the complete genome sequences of all seven gene segments of ICV in children in the Philippines between 2014 and 2019. The study was approved by the Ethics Committee of Tohoku University Graduate School of Medicine, Japan, and the Institutional Review Board of the RITM, Philippines.

We conducted a cohort study on Biliran Island from 2014 to 2019 and collected nasal or nasopharyngeal swabs from children with acute respiratory illness (12). We also collected samples from hospitalized children with severe pneumonia in a hospital-based study on Palawan Island from 2014 to 2016 (13). ICV was isolated and propagated in Madin–Darby canine kidney cell culture using a microplate method (11, 14), and total RNA in the cell culture supernatant was extracted using a QIAamp viral RNA minikit (Qiagen, Hilden, Germany). DNA libraries were generated using the TruSeq stranded mRNA LT sample prep kit and sequenced (100-bp paired-end reads) on a NovaSeq 6000 S4 flow cell on the Illumina NovaSeq 6000 platform at Macrogen Japan Corporation (Tokyo, Japan). CLC Genomics Workbench version 20.0.4 (Qiagen, Hilden, Germany) was used for data analysis. Quality control of the raw reads, including removal of adapter sequence and low-quality reads, was performed using the default settings of CLC Workbench. Consensus sequences were extracted from the mapped reads after simultaneous mapping of the reads to the following reference sequences: GenBank accession number NC_006307 for PB2, NC_006308 for PB1, NC_006309 for P3, NC_006310 for HE, NC_006311 for NP, NC_006312 for M, and NC_006306 for NS.

The average coverage per sample ranged from 5,390 to 152,413 reads (Table 1). The minimum and maximum depths of coverage in the CDS of all samples were 143 and 551,997 reads, respectively. The full length of the CDS was covered at more than 100× depth. Based on a phylogenetic analysis of the HE gene, the samples were divided into two lineages: C/Kanagawa and C/Sao Paulo (Fig. 1).

TABLE 1.

Information on complete genome sequences of influenza C virusa

Strain Yr No. of reads % GC Avg coverage (×) % of coding regions covered at ≥100× Sequence Read Archive accession no. GenBank accession no. Gene length (bp)
PB2 PB1 P3 HE NP M NS
C/Palawan/068/2014 2014 44,582,786 52.35 62,205 94.47 SRR14537525 MZ331007–MZ331013 2,325 2,265 2,130 1,968 1,698 1,125 862
C/Biliran/TB5-195/2014 2014 43,211,150 54.41 13,916 94.39 SRR14537524 MZ330944–MZ330950 2,325 2,265 2,130 1,968 1,698 1,125 862
C/Biliran/TB5-241/2014 2014 53,471,664 53.69 34,393 94.47 SRR14537514 MZ330951–MZ330957 2,325 2,265 2,130 1,968 1,698 1,125 862
C/Biliran/TB2-162/2014 2014 57,572,618 55.40 9,978 94.41 SRR14537513 MZ330881–MZ330887 2,325 2,265 2,130 1,968 1,698 1,125 862
C/Biliran/TB2-180/2014 2014 48,560,152 54.76 5,390 94.40 SRR14537512 MZ330888–MZ330894 2,325 2,265 2,130 1,968 1,698 1,125 862
C/Biliran/TB8-250/2014 2014 49,854,394 54.55 20,153 94.37 SRR14537511 MZ330993–MZ330999 2,325 2,265 2,130 1,968 1,698 1,125 862
C/Biliran/TB2-204/2014 2014 52,851,942 53.35 18,793 94.51 SRR14537510 MZ330895–MZ330901 2,325 2,265 2,130 1,968 1,698 1,125 862
C/Biliran/TB2-293/2014 2014 45,432,860 53.49 20,277 94.39 SRR14537509 MZ330902–MZ330908 2,325 2,265 2,130 1,968 1,698 1,125 862
C/Palawan/061/2015 2015 44,671,646 53.57 31,770 94.46 SRR14537508 MZ331000–MZ331006 2,325 2,265 2,130 1,968 1,698 1,125 862
C/Biliran/TB5-498/2016 2016 61,000,696 54.27 63,616 94.45 SRR14537507 MZ330965–MZ330971 2,325 2,265 2,130 1,968 1,698 1,125 862
C/Biliran/TB5-536/2016 2016 62,519,482 52.71 81,834 94.42 SRR14537523 MZ330972–MZ330978 2,325 2,265 2,130 1,968 1,698 1,125 862
C/Biliran/TB5-625/2016 2016 57,831,760 49.51 100,708 94.52 SRR14537522 MZ330979–MZ330985 2,325 2,265 2,130 1,968 1,698 1,125 862
C/Biliran/TB5-736/2016 2016 48,786,384 53.59 38,654 94.51 SRR14537521 MZ330986–MZ330992 2,325 2,265 2,130 1,968 1,698 1,125 862
C/Biliran/TB4-024/2017 2017 62,691,494 52.84 88,608 94.55 SRR14537520 MZ330909–MZ330915 2,325 2,265 2,130 1,968 1,698 1,125 862
C/Biliran/TB5-312/2017 2017 62,459,368 54.84 60,857 94.47 SRR14537519 MZ330958–MZ330964 2,325 2,265 2,130 1,968 1,698 1,125 862
C/Biliran/TB4-067/2017 2017 62,583,132 55.01 47,907 94.48 SRR14537518 MZ330916–MZ330922 2,325 2,265 2,130 1,968 1,698 1,125 862
C/Biliran/TB4-130/2018 2018 42,157,534 51.59 79,847 94.48 SRR14537517 MZ330923–MZ330929 2,325 2,265 2,130 1,968 1,698 1,125 862
C/Biliran/TB4-169/2018 2018 49,578,338 49.16 152,413 94.58 SRR14537516 MZ330930–MZ330936 2,325 2,265 2,130 1,968 1,698 1,125 862
C/Biliran/TB4-271/2019 2019 47,001,394 56.25 10,687 94.50 SRR14537515 MZ330937–MZ330943 2,325 2,265 2,130 1,968 1,698 1,125 862
a

The average coverage and percentage of coding regions covered at ≥100× were calculated for the complete sequence of the coding regions as follows: nucleotides 22 to 2346 for polymerase basic 2 (PB2), nucleotides 18 to 2282 for polymerase basic 1 (PB1), nucleotides 22 to 2151 for polymerase 3 (P3), nucleotides 22 to 1989 for hemagglutinin-esterase (HE), nucleotides 30 to 1727 for nucleoprotein (NP), nucleotides 26 to 1150 for matrix (M), and nucleotides 27 to 888 for the nonstructural (NS) gene.

FIG 1.

FIG 1

Phylogenetic tree of the influenza C virus hemagglutinin-esterase (HE) gene. For this analysis, the length of the coding region of the HE gene was 1,926 nucleotides (positions 64 to 1989). The phylogenetic tree was constructed using the neighbor-joining method in MEGA7 software, using T92 as the substitution model with gamma-distributed site heterogeneity. The bootstrap values were calculated from 1,000 replicates, and values greater than 75% are shown at the branches of the tree. Strains analyzed in this study are marked with circles: green circles for lineage C/Kanagawa and red circles for lineage C/Sao Paulo.

These nearly complete genome sequences reveal the ICV lineages that circulated between 2014 and 2019 in the Philippines.

Data availability.

The nearly complete genome sequences of 19 ICV isolates have been deposited in GenBank (accession numbers MZ330881 to MZ331013). The raw sequencing reads were deposited in the NCBI Sequence Read Archive under BioProject accession number PRJNA719209.

ACKNOWLEDGMENTS

We thank the staff at the Research Institute for Tropical Medicine (RITM), Ospital ng Palawan, Biliran Provincial Hospital, Kawayan and Caibiran Rural Health Units, and the Virology Department of Tohoku University for their support.

This study was financially supported by the Japan Initiative for Global Research Network on Infectious Diseases (J-GRID) from the Japan Agency for Medical Research and Development (AMED) (grant number JP19fm0108013), Science and Technology Research Partnership for Sustainable Development (SATREPS) at AMED, Japan International Cooperation Agency (JICA) (grant number JP16jm0110001), and the Japan Society for the Promotion of Science (JSPS) KAKENHI (grant number JP19KK0204).

Contributor Information

Clyde Dapat, Email: clyde@med.tohoku.ac.jp.

Simon Roux, DOE Joint Genome Institute.

REFERENCES

  • 1.Matsuzaki Y, Mizuta K, Kimura H, Sugawara K, Tsuchiya E, Suzuki H, Hongo S, Nakamura K. 2000. Characterization of antigenically unique influenza C virus strains isolated in Yamagata and Sendai cities, Japan, during 1992–1993. J Gen Virol 81:1447–1452. doi: 10.1099/0022-1317-81-6-1447. [DOI] [PubMed] [Google Scholar]
  • 2.Matsuzaki Y, Katsushima N, Nagai Y, Shoji M, Itagaki T, Sakamoto M, Kitaoka S, Mizuta K, Nishimura H. 2006. Clinical features of influenza C virus infection in children. J Infect Dis 193:1229–1235. doi: 10.1086/502973. [DOI] [PubMed] [Google Scholar]
  • 3.Principi N, Scala A, Daleno C, Esposito S. 2013. Influenza C virus-associated community-acquired pneumonia in children. Influenza Other Respir Viruses 7:999–1003. doi: 10.1111/irv.12062. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Matsuzaki Y, Sugawara K, Abiko C, Ikeda T, Aoki Y, Mizuta K, Katsushima N, Katsushima F, Katsushima Y, Itagaki T, Shimotai Y, Hongo S, Muraki Y, Nishimura H. 2014. Epidemiological information regarding the periodic epidemics of influenza C virus in Japan (1996–2013) and the seroprevalence of antibodies to different antigenic groups. J Clin Virol 61:87–93. doi: 10.1016/j.jcv.2014.06.017. [DOI] [PubMed] [Google Scholar]
  • 5.Kauppila J, Rönkkö E, Juvonen R, Saukkoriipi A, Saikku P, Bloigu A, Vainio O, Ziegler T. 2014. Influenza C virus infection in military recruits—symptoms and clinical manifestation. J Med Virol 86:879–885. doi: 10.1002/jmv.23756. [DOI] [PubMed] [Google Scholar]
  • 6.Gouarin S, Vabret A, Dina J, Petitjean J, Brouard J, Cuvillon-Nimal D, Freymuth F. 2008. Study of influenza C virus infection in France. J Med Virol 80:1441–1446. doi: 10.1002/jmv.21218. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Lee HS, Lim S, Noh JY, Song JY, Cheong HJ, Lee JH, Woo S, Kim WJ. 2019. Identification of influenza C virus in young South Korean children, from October 2013 to September 2016. J Clin Virol 115:47–52. doi: 10.1016/j.jcv.2019.03.016. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Njouom R, Monamele GC, Ermetal B, Tchatchouang S, Moyo-Tetang S, McCauley JW, Daniels RS. 2019. Detection of influenza C virus infection among hospitalized patients, Cameroon. Emerg Infect Dis 25:607–609. doi: 10.3201/eid2503.181213. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Jelley L, Levy A, Deng YM, Spirason N, Lang J, Buettner I, Druce J, Blyth C, Effler P, Smith D, Barr IG. 2016. Influenza C infections in Western Australia and Victoria from 2008 to 2014. Influenza Other Respir Viruses 10:455–461. doi: 10.1111/irv.12402. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Howard LM, Johnson M, Gil AI, Pekosz A, Griffin MR, Edwards KM, Lanata CF, Grijalva CG, Williams JV, RESPIRA-PERU Group . 2017. A novel real-time RT-PCR assay for influenza C tested in Peruvian children. J Clin Virol 96:12–16. doi: 10.1016/j.jcv.2017.08.014. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Odagiri T, Matsuzaki Y, Okamoto M, Suzuki A, Saito M, Tamaki R, Lupisan SP, Sombrero LT, Hongo S, Oshitani H. 2015. Isolation and characterization of influenza C viruses in the Philippines and Japan. J Clin Microbiol 53:847–858. doi: 10.1128/JCM.02628-14. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Furuse Y, Tamaki R, Okamoto M, Saito-Obata M, Suzuki A, Saito M, Imamura T, Khandaker I, Dapat I, Ueno F, Alday PP, Tan AG, Inobaya MT, Segubre-Mercado E, Tallo V, Lupisan S, Oshitani H. 2019. Association between preceding viral respiratory infection and subsequent respiratory illnesses among children: a prospective cohort study in the Philippines. J Infect Dis 219:197–205. doi: 10.1093/infdis/jiy515. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Dembele BPP, Kamigaki T, Dapat C, Tamaki R, Saito M, Saito M, Okamoto M, Igoy MAU, Mercado ES, Mondoy M, Tallo VL, Lupisan SP, Egawa S, Oshitani H. 2019. Aetiology and risks factors associated with the fatal outcomes of childhood pneumonia among hospitalised children in the Philippines from 2008 to 2016: a case series study. BMJ Open 9:e026895. doi: 10.1136/bmjopen-2018-026895. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Numazaki Y, Oshima T, Ohmi A, Tanaka A, Oizumi Y, Komatsu S, Takagi T, Karahashi M, Ishida N. 1987. A microplate method for isolation of viruses from infants and children with acute respiratory infections. Microbiol Immunol 31:1085–1095. doi: 10.1111/j.1348-0421.1987.tb01340.x. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

The nearly complete genome sequences of 19 ICV isolates have been deposited in GenBank (accession numbers MZ330881 to MZ331013). The raw sequencing reads were deposited in the NCBI Sequence Read Archive under BioProject accession number PRJNA719209.


Articles from Microbiology Resource Announcements are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES